JNJ-77242113 [JNJ-77242113-AAC] , Stelara 90mg solution for injection in pre-filled syringe [Ustekinumab] clinical trials

A study comparing JNJ-77242113 and ustekinumab in adult participants with moderate to severe plaque psoriasis

This study compares a new medicine, JNJ-77242113, with an existing one, Stelara, for adults with moderate to severe plaque psoriasis. It aims to see how well the new drug works to reduce red, scaly skin patches by targeting a protein involved in inflammation.